HARBOUR INVESTMENTS, INC. - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 69 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2022. The put-call ratio across all filers is 2.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$1,886
-0.6%
500.0%0.00%
Q2 2023$1,897
+56.0%
500.0%0.00%
Q1 2023$1,216
-16.3%
500.0%0.00%
Q4 2022$1,452
-27.4%
500.0%0.00%
Q3 2022$2,0000.0%500.0%0.00%
Q2 2022$2,000
-33.3%
500.0%0.00%
Q4 2021$3,0000.0%500.0%0.00%
Q3 2021$3,000
-25.0%
500.0%0.00%
Q2 2021$4,0000.0%500.0%0.00%
Q1 2021$4,000500.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 78,905$8,306,0007.65%
FORT, L.P. 157,584$16,589,0004.68%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 808,200$85,079,0004.39%
Strategic Global Advisors, LLC 81,432$8,572,0003.18%
Prince Street Capital Management LLC 48,700$5,127,0001.62%
Analyst IMS Investment Management Services Ltd. 31,438$3,309,0001.45%
Freestone Capital Holdings, LLC 84,900$8,937,0000.77%
RPG Investment Advisory, LLC 17,227$1,813,0000.61%
CLINTON GROUP INC 46,370$4,881,0000.28%
USA FINANCIAL FORMULAS 10,786$1,135,0000.28%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders